A carregar...
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial
IMPORTANCE: The effect of continuing vs withdrawing treatment with semaglutide, a glucagon-like peptide 1 receptor agonist, on weight loss maintenance in people with overweight or obesity is unknown. OBJECTIVE: To compare continued once-weekly treatment with subcutaneous semaglutide, 2.4 mg, with sw...
Na minha lista:
| Publicado no: | JAMA |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Medical Association
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7988425/ https://ncbi.nlm.nih.gov/pubmed/33755728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.3224 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|